Es gab 50 kürzliche Insider-Transaktionen für Sunshine Biopharma, Inc. (SBFMW), darunter 38 Käufe und 9 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.47M und die gesamten Insider-Verkäufe auf $99.32K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Roy Michel, Slilaty Steve N., Beaudoin Marc. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — SBFMW
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-01-13 |
Roy Michel |
Chief Commercial Officer |
Unbekannt |
- |
- |
- |
1 |
| 2024-03-04 |
Slilaty Steve N. |
10 Percent Owner, Officer: Chief Executive Officer |
Informierter Kauf |
100,000 |
$0.10 |
$10K |
130,000 |
| 2024-02-08 |
Slilaty Steve N. |
10 Percent Owner, Officer: Chief Executive Officer |
Informierter Kauf |
20,000 |
$0.10 |
$2K |
30,000 |
| 2024-01-26 |
Beaudoin Marc |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-11-30 |
Sebaaly Camille |
CFO/secretary |
Informierter Kauf |
30,000 |
$0.76 |
$22.91K |
174,465 |
| 2022-10-20 |
Chamoun Malek |
Director |
Veräußerung |
- |
- |
- |
3,700,000 |
| 2022-02-18 |
Slilaty Steve N. |
Chief Executive Officer |
Aktienrückgabe |
990,000 |
$0.10 |
$99K |
10,000 |
| 2022-02-10 |
Natan David |
Director |
Veräußerung |
- |
- |
- |
- |
| 2022-02-10 |
Keller Andrew Mark |
Director |
Veräußerung |
- |
- |
- |
- |
| 2021-10-31 |
Telsey Andrew I |
Director |
Veräußerung |
- |
- |
- |
3,000 |
| 2021-10-31 |
Kish James Daniel |
Director |
Unbekannt |
- |
- |
- |
2,500 |
| 2021-10-31 |
Kiderchah Rabi |
Director |
Veräußerung |
- |
- |
- |
325,000 |
| 2021-01-06 |
Slilaty Steve N. |
Chief Executive Officer |
RSU-Zuteilung |
20,000,000 |
$0.00 |
$20K |
23,343,461 |
| 2021-01-06 |
Sebaaly Camille |
CFO/secretary |
RSU-Zuteilung |
20,000,000 |
$0.00 |
$20K |
23,893,086 |
| 2021-01-06 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
20,000,000 |
$0.00 |
$20K |
23,342,500 |
| 2020-06-17 |
Slilaty Steve N. |
Chief Executive Officer |
RSU-Zuteilung |
500,000 |
$0.10 |
$50K |
1,000,000 |
| 2019-12-31 |
Slilaty Steve N. |
Chief Executive Officer |
Sonstige (Kauf) |
323,673 |
$0.00 |
$323.67 |
861,209 |
| 2019-12-31 |
Sebaaly Camille |
CFO/secretary |
RSU-Rückgabe |
323,673 |
$0.00 |
$323.67 |
- |
| 2019-12-19 |
Slilaty Steve N. |
Chief Executive Officer |
RSU-Zuteilung |
1,300,000 |
$0.00 |
$1.3K |
3,343,461 |
| 2019-12-19 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
1,300,000 |
$0.00 |
$1.3K |
3,342,500 |
| 2019-12-19 |
Sebaaly Camille |
CFO/secretary |
RSU-Zuteilung |
1,300,000 |
$0.00 |
$1.3K |
3,893,086 |
| 2019-10-20 |
Slilaty Steve N. |
Chief Executive Officer |
RSU-Zuteilung |
1,100,000 |
$0.00 |
$1.1K |
2,043,461 |
| 2019-10-20 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
1,100,000 |
$0.00 |
$1.1K |
2,042,500 |
| 2019-10-20 |
Sebaaly Camille |
CFO/secretary |
RSU-Zuteilung |
1,100,000 |
$0.00 |
$1.1K |
2,593,086 |
| 2019-09-11 |
Sebaaly Camille |
10 Percent Owner, Officer: Secretary |
RSU-Zuteilung |
11,000,000 |
$0.00 |
$11K |
29,861,719 |
| 2019-09-11 |
Sebaaly Camille |
CFO/secretary |
RSU-Zuteilung |
550,000 |
$0.00 |
$550.00 |
1,493,086 |
| 2019-09-02 |
Slilaty Steve N. |
10 Percent Owner, Officer: Chief Executive Officer |
RSU-Zuteilung |
13,000,000 |
$0.00 |
$13K |
18,869,219 |
| 2019-09-02 |
Sebaaly Camille |
10 Percent Owner, Officer: Secretary |
RSU-Zuteilung |
13,000,000 |
$0.00 |
$13K |
18,861,719 |
| 2019-09-02 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
13,000,000 |
$0.00 |
$13K |
18,850,000 |
| 2018-08-27 |
Slilaty Steve N. |
Chief Executive Officer |
RSU-Zuteilung |
38,000,000 |
$0.00 |
$38K |
117,384,373 |
| 2018-08-27 |
Sebaaly Camille |
Secretary |
RSU-Zuteilung |
38,000,000 |
$0.00 |
$38K |
117,234,373 |
| 2018-08-27 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
38,000,000 |
$0.00 |
$38K |
118,467,000 |
| 2018-08-27 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
38,000,000 |
$0.00 |
$38K |
117,000,000 |
| 2018-06-20 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
27,000,000 |
$0.00 |
$27K |
79,000,000 |
| 2018-06-20 |
Slilaty Steve N. |
Chief Executive Officer |
RSU-Zuteilung |
27,000,000 |
$0.00 |
$27K |
79,384,373 |
| 2018-06-20 |
Sebaaly Camille |
Secretary |
RSU-Zuteilung |
27,000,000 |
$0.00 |
$27K |
79,234,373 |
| 2018-06-20 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
27,000,000 |
$0.00 |
$27K |
80,467,000 |
| 2018-04-22 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
12,000,000 |
$0.00 |
$12K |
12,000,000 |
| 2017-07-20 |
Slilaty Steve N. |
Chief Executive Officer |
RSU-Zuteilung |
14,000,000 |
$0.00 |
$14K |
52,384,373 |
| 2017-07-20 |
Sebaaly Camille |
Secretary |
RSU-Zuteilung |
14,000,000 |
$0.00 |
$14K |
52,234,373 |
| 2017-07-20 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
14,000,000 |
$0.00 |
$14K |
53,467,000 |
| 2017-07-20 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
14,000,000 |
$0.00 |
$14K |
52,000,000 |
| 2016-12-06 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
28,000,000 |
$0.00 |
$28K |
38,000,000 |
| 2016-12-06 |
Slilaty Steve N. |
Chief Executive Officer |
RSU-Zuteilung |
26,000,000 |
$0.00 |
$26K |
38,384,373 |
| 2016-12-06 |
Sebaaly Camille |
CFO and Secretary |
RSU-Zuteilung |
26,000,000 |
$0.00 |
$26K |
38,234,373 |
| 2016-12-06 |
Merzouki Abderrazzak |
Chief Operating Officer |
RSU-Zuteilung |
26,000,000 |
$0.00 |
$26K |
39,467,000 |
| 2016-10-10 |
Slilaty Steve N. |
10 Percent Owner, Officer: Chief Executive Officer |
Sonstige (Verkauf) |
136,861,968 |
- |
- |
215,014,224 |
| 2016-10-10 |
Sebaaly Camille |
10 Percent Owner, Officer: CFO and Secretary |
Sonstige (Kauf) |
129,468,927 |
- |
- |
129,468,927 |
| 2016-10-10 |
Advanomics Corp |
10 Percent Owner |
Sonstige (Verkauf) |
136,861,968 |
- |
- |
215,014,224 |
| 2016-07-08 |
Slilaty Steve N. |
10 Percent Owner, Officer: Chief Executive Officer |
Sonstige (Kauf) |
321,305,416 |
$0.00 |
$835.39K |
351,876,192 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
